ATI RN
ATI RN Pharmacology Exam 2024 With NGN Questions
Question 1 of 5
A nurse is assessing a client after administering a second dose of cefazolin IV. The nurse notes the client has anxiety, hypotension. and dyspneWhich of the following medications should the nurse administer first?
Correct Answer: C
Rationale: The correct answer is C: Epinephrine. Epinephrine is a potent vasoconstrictor and bronchodilator, which helps reverse hypotension and dyspnea, potentially caused by an allergic reaction to cefazolin. Administering epinephrine first is crucial to address the life-threatening symptoms. Diphenhydramine (choice
A) is an antihistamine that can help with itching but is not as urgent. Albuterol inhaler (choice
B) treats bronchospasm but doesn't address hypotension. Prednisone (choice
D) is a corticosteroid that may be used later for inflammation but is not the first-line treatment for acute symptoms.
Question 2 of 5
Which of the following statements should the nurse include in the teaching about the new medication? Select the 2 statements the nurse should include in the teaching.
Correct Answer: B, D
Rationale: The nurse should include statements B and D in the teaching about the new medication. Statement B is important as it informs the patient about a potential side effect (constipation) of the medication, empowering them to monitor for and manage this issue. Statement D is crucial as certain medications can increase sensitivity to sunlight, leading to adverse effects. This instruction helps prevent potential harm. Statements A, C, E, F, and G are incorrect. Statement A is false because taking medication with dairy products can interfere with absorption. Statement C, E, F, and G are not relevant to the medication's specific instructions or potential side effects.
Question 3 of 5
For which of the following adverse effects should the nurse instruct the client taking acetazolamide for chronic open-angle glaucoma to monitor and report?
Correct Answer: A
Rationale: The correct answer is A, tingling of fingers. Acetazolamide is a diuretic that can lead to electrolyte imbalances, such as hypokalemia, causing tingling sensations in the extremities. Constipation (
B) is not a common side effect of acetazolamide. Weight gain (
C) is unlikely as acetazolamide is a diuretic that typically causes fluid loss. Oliguria (
D) is not a typical adverse effect of acetazolamide, as it is more likely to increase urine output.
Question 4 of 5
Which of the following actions is the priority for the nurse to take after inadvertently administering 160 mg of valsartan PO to a client who was scheduled to receive 80 mg?
Correct Answer: A
Rationale: The correct answer is A: Evaluate the client for orthostatic hypotension. After administering double the prescribed dose of valsartan, the nurse's priority is to assess the client for potential adverse effects, such as a sudden drop in blood pressure leading to orthostatic hypotension. This is crucial for immediate intervention to prevent complications.
B: Monitoring urine output is important but not the priority after an overdose.
C: Obtaining laboratory results may be necessary later but is not the immediate action needed.
D: Checking for nasal congestion is unrelated to the overdose of valsartan.
In summary, choice A is correct as it addresses the immediate concern of potential adverse effects, while the other choices are not the priority given the situation.
Question 5 of 5
A nurse is caring for a client who received 0.9% sodium chloride 1 L over 4 hr instead of over 8 hr as prescribeWhich of the following information should the nurse enter as a complete documentation of the incident?
Correct Answer: B
Rationale:
Correct Answer: B
Rationale: Option B provides a complete documentation of the incident by stating the specific IV fluid, volume, rate, and duration of infusion, along with the client's vital signs and the action taken (provider notified). This information is crucial for accurately documenting the deviation from the prescribed infusion rate and the client's response.
Summary of Other
Choices:
A: Does not mention vital signs or completion of the infusion. Lacks specificity.
C: Does not address the deviation in the infusion rate or vital signs. Irrelevant information.
D: Mentions the initiation time and lung sounds, but does not address the deviation in infusion rate or client response.
E: Similar to option B but lacks specificity regarding the duration of the infusion.